• 1
    Kim J.J., Accili D., Naomi B. (2002) Signalling through IGF-I and insulin receptors: where is the specificity? Growth Horm IGF Res;12:84.
  • 2
    Furstenberger G., Senn H.-J. (2002) Insulin-like growth factors and cancer. Lancet Oncol;3:298.
  • 3
    Gross J.M., Yee D. (2003) The type-1 insulin-like growth factor receptor tyrosine kinase and breast cancer: Biology and therapeutic relevance. Cancer Metastasis Rev;22:327.
  • 4
    Yu H., Rohan T. (2000) Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst;92:1472.
  • 5
    Bohula E.A., Playford M.P., Macaulay V.M. (2003) Targeting the type 1 insulin-like growth factor receptor as anti-cancer treatment. Anticancer Drugs;14:669.
  • 6
    Zhang H., Yee D. (2004) The therapeutic potential of agents targeting the type I insulin-like growth factor receptor. Expert Opin Investig Drugs;13:1569.
  • 7
    Gualberto A., Pollak M. (2009) Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions. Oncogene;28:3009.
  • 8
    Cox P.J., Majid T.N., Lai J.Y.Q., Morley A.D., Amendola S., Deprets S., Edlin C. (2001) Preparation of azaindoles as protein kinase inhibitors. PCT Int Appl 270 WO 03/000688 A1.
  • 9
    Wittman M., Carboni J., Attar R., Balasubramanian B., Balimane P., Brassil P., Beaulieu F. et al. (2005) Discovery of a 1H-Benzoimidazol-2-yl-1H-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity. J Med Chem;48:5639.
  • 10
    Yuen J.S.P., Macaulay V.M. (2008) Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Expert Opin Ther Targets;12:589.
  • 11
    Garcıa-Echeverrıa C., Pearson M.A., Marti A., Meyer T., Mestan J., Zimmermann J., Gao J. et al. (2004) In vivo antitumor activity of NVP-AEW541 as a novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell;5:231.
  • 12
    Ghose A.K., Herbertz T., Pippin D.A., Salvino J.M., Mallamo J.P. (2008) Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery. J Med Chem;51:5149.
  • 13
    Munshi S., Kornienko M., Hall D.L., Reid J.C., Waxman L., Stirdivant S.M., Darke P.L., Kuo L.C (2002) Crystal structure of the apo, unactivated insulin-like growth factor-1 receptor kinase. Implication for inhibitor specificity. J Biol Chem;277:38797.
  • 14
    Pautsch A., Zoephel A., Ahorn H., Spevak W., Hauptmann R., Nar H. (2001) Crystal structure of bisphosphorylated IGF-1 receptor kinase. Insight into domain movements upon kinase activation. Structure (Cambridge, MA, United States);9:955.
  • 15
    Favelyukis S., Till J.H., Hubbard S.R., Miller W.T. (2001) Structure and autoregulation of the insulin-like growth factor 1 receptor kinase. Nat Struct Biol;8:1058.
  • 16
    Wentzler S., El Ahmad Y., Filoche Romme B., Nemecek C., Venot C. (2005) Fr. Demande 217 pp.; WO2006/037875.
  • 17
    Kumar V., Dority J.A., Bacon E.R., Singh B., Lesher G.Y. (1992) Synthesis of 7-azaindole and 7-azaoxindole derivatives through a palladium-catalyzed cross-coupling reaction. J Org Chem;57:6997.
  • 18
    Koradin C., Dohle W., Rodriguez A.L., Schmid B., Knochel P. (2003) Synthesis of polyfunctional indoles and related heterocycles mediated by cesium and potassium bases. Tetrahedron;59:1571.
  • 19
    Nemecek C., Metz W., Wentzler S., Lesuisse D. (2006) Fr. Demande 110 pp. WO2005/095399.
  • 20
    O’Neill B.T., Yohannes D., Bundesmann M.W., Arnold E.P. (2000) Total synthesis of (+/-)-cytisine. Org Lett;2:4201.
  • 21
    Sinhababu A.K., Borchardt R.T. (1988) Independent synthesis of 5-hydroxytryptamine-4,7-dione, the neurocytotoxic product of autoxidation of 5,7-dihydroxytryptamine. J Heterocycl Chem;1988:25.
  • 22
    Rosini G., Ballini R., Sorrenti P. (1983) Synthesis of 2-nitroalkanols on alumina surfaces without solvent: a simple, mild and convenient method.. Synthesis;6:10141016.
  • 23
    Henry L. (1895) Formation. synthétique d’alcools nitrés. C R Acad Sci Paris;120:1265.
  • 24
    Novellino L., D’Ischia M., Prota G. (1999) Expedient Synthesis of 5,6-Dihydroxyindole and Derivatives via an Improved Zn(II)-Assisted 2,b-Dinitrostyrene Approach. Synthesis;5:793796.
  • 25
    Sinhababu A.K., Borchardt R.T. (1983) Silica gel-assisted reduction of nitrostyrenes to 2-aryl-2-[2H]-1-nitroethanes with sodium borodeuteride. J Org Chem;48:3347.